# Everolimus Post Orthotopic Liver Transplant

> **NCT01998789** · PHASE2 · UNKNOWN · sponsor: **Tomoaki Kato** · enrollment: 50 (estimated)

## Conditions studied

- Orthotopic Liver Transplant

## Interventions

- **DRUG:** Everolimus
- **DRUG:** Standard Tacrolimus

## Key facts

- **NCT ID:** NCT01998789
- **Lead sponsor:** Tomoaki Kato
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2018-06
- **Final completion:** 2019-02
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-08-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01998789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01998789, "Everolimus Post Orthotopic Liver Transplant". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT01998789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*